• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CHIME Suspends National Patient ID Challenge After 2 Years

by Jasmine Pennic 11/15/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

CHIME National Patient ID Challenge

The College of Healthcare Information Management Executives (CHIME), today announced that CHIME Healthcare Innovation Trust has decided to suspend the National Patient ID Challenge after nearly two years of work. Despite the suspension, CHIME did emphasized that finding a national patient ID solution that accurately identifies a patient 100% percent of the time will remain a top priority.

Launched in 2015, CHIME National Patient ID Challenge is a $1 million global competition aimed at incentivizing new, early-stage, and experienced innovators to accelerate the creation and adoption of a solution for ensuring 100% accuracy in identifying patients in the U.S.  Patients want the right treatment and providers want information about the right patient to provide the right treatment. It is estimated that the current accuracy rate of patient ID matching at even the most sophisticated hospitals is only around 80 percent, which means that there is a 1 in 5 chance that a patient’s safety, privacy or security will be compromised.

As part of the next steps, CHIME will assist in developing a Patient Identification Task Force through CHIME Healthcare Innovation Trust, the CHIME affiliate that sponsored the CHIME National Patient ID Challenge. CHIME commends the Challenge innovators for their commitment to improving healthcare and is encouraging them to participate on the task force moving forward.

“We firmly believe that accurate patient identification is fundamental to patient care today and that innovation will lead to better, more affordable, more accessible and more equitable care,” said Russell Branzell, president and CEO of CHIME in a statement. “Though we’ve made great progress and moved the industry forward in many ways through the Challenge, we ultimately did not achieve the results we sought to this complex problem. We decided the best course for addressing this patient safety hazard is to redirect our attention and resources to another strategy.”

“We will continue to lead, but we cannot do this alone,” Branzell said, noting that Washington has signaled a possible easing of restrictions on supporting a national patient identification solution. Still, these actions are not sufficient to meet CHIME’s goals. “We need industry and government to join us with the same level of passion and commitment that our members show in their positions as CIOs and senior health IT executives.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: CHIME, National Patient ID Challenge

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |